CADL vs CHWY · $592.0M cap vs P/E 45, rev $12.60B
Candel Therapeutics Inc (CADL) versus Chewy Inc (CHWY) — a side-by-side from cached financials, not a winner call.
Candel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
Chewy Inc (CHWY) is a internet retail company listed on US.
CADL does not have a complete income-statement cache yet.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
CADL currently screens at market cap $592.0M. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Not investment advice. Open the CADL and CHWY stock pages for the full models.
Not investment advice.